Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Selina Mader actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
-
ROBO1 Defines Therapy-Resistant Persister Cells in Pancreatic Cancer
Mader, S., 2025, (Unpublished). 1 blz.Onderzoeksoutput: Poster
-
ROBO1 Defines Therapy-Resistant Persister Cells in Pancreatic Cancer
Mader, S. & Rooman, I., 2025, (Unpublished). 1 blz.Onderzoeksoutput: Poster
-
ROBO1 Drives Gemcitabine Resistance in Pancreatic Cancer
Mader, S., Rodriguez Aznar, E. & Rooman, I., 2025, (Unpublished).Onderzoeksoutput: Poster
-
ROBO1 Drives Gemcitabine Resistance in Pancreatic Cancer
Mader, S., Rooman, I., Rodriguez Aznar, E., Soubeyran, P., Dusetti, N. & Bousquet Vaysse, C., 17 jun. 2024, (Unpublished).Onderzoeksoutput: Poster
-
ROBO1 Drives Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
Mader, S., Soubeyran, P., Dusetti, N., Bousquet Vaysse, C., Rodriguez Aznar, E. & Rooman, I., 2024, (Unpublished).Onderzoeksoutput: Poster
Prijzen
-
Wetenschappelijk Fonds Willy Gepts: Investigating the Therapeutic Potential of ROBO1 CAR-NK Immunotherapy in PancreaticDuctal Adenocarcinoma: Exploring Synergies with Gemcitabine
Rooman, I. (Recipient), Mader, S. (Recipient), Breckpot, K. (Recipient) & Messaoudi, N. (Recipient), 2024
Prijs: Prize (including medals and awards)
-
LKI Vesalius Conference on Cancer Research 2026
Mader, S. (Participant)
18 jan. 2026 → 20 jan. 2026Activiteit: Participation in conference
-
-
ROBO1 Defines Therapy-Resistant Persister Cells in Pancreatic Cancer
Mader, S. (Speaker)
2 dec. 2025Activiteit: Talk or presentation at a conference
-
ROBO1 Defines Therapy-Resistant Persister Cells in Pancreatic Cancer
Mader, S. (Speaker)
31 dec. 2017Activiteit: Talk or presentation at a conference